Amendment to Amended and Restated Investment Sub-Advisory Agreement Between Jackson National Asset Management, LLC and Mellon Capital Management Corporation
EX 99.28(d)(45)(xvii)
Amendment
to Amended and Restated
Investment Sub-Advisory Agreement Between
Xxxxxxx National Asset Management, LLC
and Mellon Capital Management Corporation
This Amendment is made by and between Xxxxxxx National Asset Management, LLC, a Michigan limited liability company and registered investment adviser (the “Adviser”), and Mellon Capital Management Corporation, a Delaware corporation and registered investment adviser (the “Sub-Adviser”).
Whereas, the Adviser and Sub-Adviser (the “Parties”) entered into an Amended and Restated Investment Sub-Advisory Agreement effective as of the 1st day of December, 2012, as amended (the “Agreement”), whereby the Adviser appointed the Sub-Adviser to provide certain sub-investment advisory services to certain investment portfolios (the “Funds”) of JNL Series Trust, as listed on Schedule A of the Agreement.
Whereas, pursuant to the Agreement, the Adviser agreed to pay the Sub-Adviser for the services provided and the expenses assumed by the Sub-Adviser a sub-advisory fee as set forth on Schedule B to the Agreement, and the Sub-Adviser agreed to accept such sub-advisory fee as full compensation under the Agreement for such services and expenses.
Whereas, the Parties agreed to amend the sub-advisory fees, as set forth on Schedule B to the Agreement, to reflect fee reductions for the following three funds, effective July 1, 2017:
| 1) |
JNL/Mellon Capital Emerging Markets Index Fund;
|
| 2) |
JNL/Mellon Capital Pacific Rim 30 Fund; and
|
| 3) |
JNL/Mellon Capital European 30 Fund.
|
Now Therefore, in consideration of the mutual covenants herein contained, the Parties hereby agree to amend the Agreement as follows:
| 1) |
Schedule B to the Agreement is hereby deleted and replaced in its entirety with Schedule B dated July 1, 2017, attached hereto.
|
| 2) |
Except as specifically amended hereby, the Agreement shall remain in full force and effect in accordance with its terms.
|
| 3) |
Each of the Parties represents and warrants to the others that it has full authority to enter into this Amendment upon the terms and conditions hereof and that the individual executing this Amendment is duly authorized to bind the respective party to this Amendment.
|
| 4) |
This Amendment may be executed in one or more counterparts, which together shall constitute one document.
|
In Witness Whereof, the Parties have caused this Amendment to be executed, effective as of July 1, 2017.
|
Xxxxxxx National Asset Management, LLC
|
Mellon Capital Management Corporation
|
|||
|
By:
|
/s/ Xxxx X. Xxxxx
|
By:
|
/s/ Xxxxxx Xxxxx
|
|
|
Name:
|
Xxxx X. Xxxxx
|
Name:
|
Xxxxxx Xxxxx
|
|
|
Title:
|
President and CEO
|
Title:
|
Managing Director
|
|
Schedule B
Dated July 1, 2017
(Compensation)
|
|
|
|
JNL/Mellon Capital Bond Index Fund
|
|
|
Average Daily Net Assets
|
Annual Rate
|
|
$0 to $750 million
|
0.03%
|
|
$750 million to $2 billion
|
0.015%
|
|
Over $2 billion
|
0.010%
|
|
|
|
|
JNL/Mellon Capital Emerging Markets Index Fund
|
|
|
Average Daily Net Assets
|
Annual Rate
|
|
$0 to $750 million
|
0.03%
|
|
$750 million to $2 billion
|
0.015%
|
|
Over $2 billion
|
0.010%
|
|
JNL/Mellon Capital European 30 Fund
|
|
|
Average Daily Net Assets
|
Annual Rate
|
|
$0 to $50 million
|
0.06%
|
|
$50 million to $100 million
|
0.06%
|
|
$100 million to $750 million
|
0.03%
|
|
Over $750 million
|
0.015%
|
|
JNL/Mellon Capital International Index Fund
|
|
|
Average Daily Net Assets
|
Annual Rate
|
|
$0 to $750 million
|
0.03%
|
|
$750 million to $2 billion
|
0.015%
|
|
Over $2 billion
|
0.010%
|
|
JNL/Mellon Capital MSCI KLD 400 Social Index Fund
|
|
|
Average Daily Net Assets
|
Annual Rate
|
|
$0 to $750 million
|
0.03%
|
|
$750 million to $2 billion
|
0.015%
|
|
Over $2 billion
|
0.010%
|
B-1
|
JNL/Mellon Capital Pacific Rim 30 Fund
|
|
|
Average Daily Net Assets
|
Annual Rate
|
|
$0 to $100 million
|
0.06%
|
|
$100 million to $750 million
|
0.03%
|
|
Over $750 million
|
0.015%
|
|
JNL/Mellon Capital S&P 500 Index Fund
|
|
|
Average Daily Net Assets
|
Annual Rate
|
|
All Assets
|
0.01%
|
|
JNL/Mellon Capital S&P 400 MidCap Index Fund
|
|
|
Average Daily Net Assets
|
Annual Rate
|
|
All Assets
|
0.01%
|
|
JNL/Mellon Capital Small Cap Index Fund
|
|
|
Average Daily Net Assets
|
Annual Rate
|
|
All Assets
|
0.01%
|
|
JNL/Mellon Capital Utilities Sector Fund
|
|
|
Average Daily Net Assets
|
Annual Rate
|
|
$0 to $750 million
|
0.03%
|
|
$750 million to $2 billion
|
0.015%
|
|
Over $2 billion
|
0.010%
|
|
JNL/S&P Competitive Advantage Fund
|
|
|
Average Daily Net Assets
|
Annual Rate
|
|
$0 to $100 million
|
0.06%
|
|
$100 million to $750 million
|
0.03%
|
|
Over $750 million
|
0.015%
|
B-2
|
JNL/S&P Dividend Income & Growth Fund
|
|
|
Average Daily Net Assets
|
Annual Rate
|
|
$0 to $100 million
|
0.06%
|
|
$100 million to $750 million
|
0.03%
|
|
Over $750 million
|
0.015%
|
|
JNL/S&P International 5 Fund
|
|
|
Average Daily Net Assets
|
Annual Rate
|
|
$0 to $100 million
|
0.06%
|
|
$100 million to $750 million
|
0.03%
|
|
Over $750 million
|
0.015%
|
|
JNL/S&P Intrinsic Value Fund
|
|
|
Average Daily Net Assets
|
Annual Rate
|
|
$0 to $100 million
|
0.06%
|
|
$100 million to $750 million
|
0.03%
|
|
Over $750 million
|
0.015%
|
|
JNL/S&P Mid 3 Fund
|
|
|
Average Daily Net Assets
|
Annual Rate
|
|
$0 to $100 million
|
0.06%
|
|
$100 million to $750 million
|
0.03%
|
|
Over $750 million
|
0.015%
|
|
JNL/S&P Total Yield Fund
|
|
|
Average Daily Net Assets
|
Annual Rate
|
|
$0 to $100 million
|
0.06%
|
|
$100 million to $750 million
|
0.03%
|
|
Over $750 million
|
0.015%
|
B-3
|
JNL/X. Xxxx Price Mid-Cap Growth Fund*
|
|
|
Average Daily Net Assets
|
Annual Rate
|
|
$0 to $50 million
|
0.09%
|
|
$50 million to $100 million
|
0.06%
|
|
$100 million to $750 million
|
0.03%
|
|
Over $750 million
|
0.015%
|
|
*Fees will be paid based on assets invested in the mid-cap growth index strategy portion of the JNL/X. Xxxx Price Mid-Cap Growth Fund managed by Mellon Capital Management Corporation.
|
B-4
